Saskia Van Selm
Nijmegen, GE, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Bifidobacterium-driven immunoglobulin A production in pediatric patients with IgA deficiency and recurrent respiratory tract infections.
Journal: Microbiome
Published: September 11, 2025
Intradermal administration of the pneumococcal conjugate vaccine in mice results in lower antibody responses as compared to intramuscular administration.
Journal: Vaccine
Published: August 25, 2022
Intranasal Vaccination With Lipoproteins Confers Protection Against Pneumococcal Colonisation.
Journal: Frontiers in immunology
Published: July 18, 2018
Th17-Mediated Cross Protection against Pneumococcal Carriage by Vaccination with a Variable Antigen.
Th17-Mediated Cross Protection against Pneumococcal Carriage by Vaccination with a Variable Antigen.
Journal: Infection and immunity
Published: April 19, 2017
Genetic background impacts vaccine-induced reduction of pneumococcal colonization.
Journal: Vaccine
Published: April 06, 2017
Agglutination by anti-capsular polysaccharide antibody is associated with protection against experimental human pneumococcal carriage.
Journal: Mucosal immunology
Published: April 21, 2016
Invasive pneumococcal disease leads to activation and hyperreactivity of platelets.
Journal: Thrombosis research
Published: April 05, 2016
Role of antibodies and IL17-mediated immunity in protection against pneumococcal otitis media.
Journal: Vaccine
Published: December 16, 2015
Alternative Pathway Inhibition by Exogenous Factor H Fails to Attenuate Inflammation and Vascular Leakage in Experimental Pneumococcal Sepsis in Mice.
Journal: PloS one
Published: December 04, 2015
Complement Factor H Serum Levels Determine Resistance to Pneumococcal Invasive Disease.
Journal: The Journal of infectious diseases
Published: November 24, 2015
Last Updated: 09/26/2026